Tuesday, November 20, 2018 4:35:02 PM
Christina Farr | @chrissyfarr
CNBC.com
In a show of transparency, Verily posted a blog post on Friday explaining why it is hitting the pause button on its glucose-sensing contact lens.
The project was first announced in 2014, back when Verily was known as Google Life Sciences.
It will shift focus to other eye-related projects, the company said.
Google smart contact lens to measure glucose levels in tears.
Source: Google
Google smart contact lens to measure glucose levels in tears.
Verily, Alphabet's life sciences arm, has paused work on its so-called "smart lens" program, which was aiming to put tiny sensors on contact lenses to measure blood sugar levels in tears.
If it worked, the lenses could help diabetics track their glucose levels in real time and in less invasive ways than the traditional meters that require piercing the skin. But in a blog post on Friday, Verily said that after four years of research it has determined that detecting blood sugar in tears is a massive — and potentially insurmountable — technical and scientific undertaking.
"Our clinical work on the glucose-sensing lens demonstrated that there was insufficient consistency in our measurements of the correlation between tear glucose and blood glucose concentrations to support the requirements of a medical device," the company said.
Verily made a big splash when if first launched the program in 2014, while it was still known as Google Life Sciences. The company partnered with Alcon, Novartis' eye-care division, on the project. However, it's been quiet about the project in the past few years, leading to speculation that it was winding down.
Verily said it did have some success with the experiment in a controlled environment, but not in actual tests because of the dynamic environment of the eye. It's a problem that goes beyond Verily.
Recent KNW News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/24/2024 09:00:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2024 09:23:58 PM
- Know Labs Study Published in IEEE Sensors Journal • Business Wire • 09/10/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 01:25:14 PM
- Know Labs, Inc. Announces $1.655 Million Public Offering • Business Wire • 08/16/2024 01:16:00 PM
- Know Labs, Inc. Reports Third Quarter FY 2024 Results • Business Wire • 08/14/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 10:01:40 AM
- Know Labs, Inc. Announces Closing of $3.445 Million Public Offering • Business Wire • 08/12/2024 10:38:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/12/2024 09:00:15 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/08/2024 04:15:14 AM
- Know Labs, Inc. Announces Pricing of $3.445 Million Public Offering • Business Wire • 08/08/2024 12:50:00 AM
- Know Labs, Inc. to Host Review of Third Quarter Fiscal Year 2024 Results on August 14, 2024 • Business Wire • 08/06/2024 01:00:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/02/2024 08:15:55 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/25/2024 01:49:42 AM
- Know Labs Publishes Clinical Results in Leading Diabetes Journal • Business Wire • 07/11/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2024 10:05:56 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/09/2024 08:38:26 PM
- Know Labs to Present at the American Diabetes Association’s Scientific Sessions • Business Wire • 06/21/2024 10:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 06/17/2024 08:52:17 PM
- Know Labs Joins the Industrial Participant Program of the Wyss Institute for Biologically Inspired Engineering at Harvard University • Business Wire • 06/05/2024 01:00:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 06/03/2024 06:11:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/29/2024 08:15:29 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM